cas 186407-74-9|| where to buy 4-bromo-1H-indazole

Produktname:4-bromo-1H-indazole

IUPAC Name:4-bromo-1H-indazole

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM100729-1000g	in stock	ƞźȀ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 186407-74-9 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:186407-74-9; Molekulare Formel:C7H5BrN2; Schmelzpunkt:-; SMILES-Code:BrC1=C2C=NNC2=CC=C1; Dichte:1.77 g/cm3

: Katalognummer:CM100729; Molekulargewicht:197.04; Siedepunkt:333.8°C at 760 mmHg; Mdl-Nr.:MFCD05664001; Lagerung:Store at room temperature.

: Indazoles; Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.

: Camizestrant; Recently, Evaluate Pharma released an analysis report on the trends in the biopharmaceutical industry in 2024. The report mentioned 10 potential key R&D pipelines, including the small molecule drug camizestrant. Camizestrant is a next-generation oral SERD and pure Erα antagonist that has demonstrated anti-cancer activity across a range of preclinical models, including in patients with ER-activating mutations.